4Jianhui Zhu, Quyyumi AA, Norman JE, et al, Effects of total pathogen burden on coronary artery disease risk and C - reactive protein levels[J] .Am J Cardiol,2000,85 : 140 - 146.
5Wolf MG,Zasmeta G, Homykewycz S, et al. Plasma levels of C - reactive prorein after coronary stent implantation[J] .Eur Heart J,2000,21:1152 - 1158.
6Lenine B, Kalman J, Mayer L, et al. Elevated circulating levels of tumor necrosis factor in severe chronic heart failure[J]. N Eng J Med, 1990,323:236- 241.
7Gabay C, Kushner I. Actue - phase proteins and other systemic responses to inflammation[J]. N Eng Med, 1999,340:448 - 454.
8Tataru MC,Heinrich J,Junker R,et al.C - reactive protein and the severity of atherosclerosis in myocardial infarction patients with stable angina pectoris[J]. Eur Heart J,2000,21 : 1000.
9Albert MA, Staggers J, Chew P, et al. Investigators. The pravastatin inflammation CRP evaluation ( PRINCE ) : rationale and design [ J ]. Am Heart J,2001,141(6) :893 - 898.
10Ridker PM, Rifai N, Clearfield M, et ,ak. Measurement - C - reactive protein for the targeting of statin therapy in the primary prevention of acute coronary events[ J], N Engl J Med, 2001,344(26) : 1959 - 1965.
